{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:38:06Z","timestamp":1767454686311,"version":"3.48.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"DOI":"10.7759\/cureus.100688","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:35:07Z","timestamp":1767454507000},"source":"Crossref","is-referenced-by-count":0,"title":["Three Interesting Cases of Hypoglycemia: A Case Series"],"prefix":"10.7759","author":[{"given":"Binod","family":"Prusty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijay","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayanidhi","family":"Meher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep K","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devadarshini","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00226","article-title":"Central mechanisms of glucose sensing and counterregulation in defense of hypoglycemia","volume":"40","author":"Stanley S","year":"2019","unstructured":"Stanley S, Moheet A, Seaquist ER. Central mechanisms of glucose sensing and counterregulation in defense of hypoglycemia. Endocr Rev. 2019, 40:768-88. 10.1210\/er.2018-00226","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504273321707","article-title":"Hypoglycemic disorders","volume":"332","author":"Service FJ","year":"1995","unstructured":"Service FJ. Hypoglycemic disorders. N Engl J Med. 1995, 332:1144-52. 10.1056\/NEJM199504273321707","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-193506000-00001","article-title":"Adenoma of islet cells with hyperinsulinism: a review","volume":"101","author":"Whipple AO","year":"1935","unstructured":"Whipple AO, Frantz VK. Adenoma of islet cells with hyperinsulinism: a review. Ann Surg. 1935, 101:1299-335. 10.1097\/00000658-193506000-00001","journal-title":"Ann Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer PE","year":"2009","unstructured":"Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009, 94:709-28. 10.1210\/jc.2008-1410","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2020.16.2.168","article-title":"Insulin autoimmune syndrome - a case series","volume":"16","author":"Boro H","year":"2020","unstructured":"Boro H, Gupta U, Singh C, Malhotra R, Khadgawat R. Insulin autoimmune syndrome - a case series. Eur Endocrinol. 2020, 16:168-71. 10.17925\/EE.2020.16.2.168","journal-title":"Eur Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diab.33.3.301","article-title":"Characterization of the serum from a patient with insulin resistance and hypoglycemia: evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities","volume":"33","author":"De Pirro R","year":"1984","unstructured":"De Pirro R, Roth RA, Rossetti L, Goldfine ID. Characterization of the serum from a patient with insulin resistance and hypoglycemia: evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities. Diabetes. 1984, 33:301-4. 10.2337\/diab.33.3.301","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181a5b42e","article-title":"Autoimmune forms of hypoglycemia","volume":"88","author":"Lupsa BC","year":"2009","unstructured":"Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore). 2009, 88:141-53. 10.1097\/MD.0b013e3181a5b42e","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.163376","article-title":"Insulin autoimmune syndrome: 73 cases of clinical analysis","volume":"128","author":"Wang YL","year":"2015","unstructured":"Wang YL, Yao PW, Zhang XT, Luo ZZ, Wu PQ, Xiao F. Insulin autoimmune syndrome: 73 cases of clinical analysis. Chin Med J (Engl). 2015, 128:2408-9. 10.4103\/0366-6999.163376","journal-title":"Chin Med J (Engl)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90080-m","article-title":"Strong association of insulin autoimmune syndrome with HLA-DR4","volume":"339","author":"Uchigata Y","year":"1992","unstructured":"Uchigata Y, Kuwata S, Tokunaga K, et al.. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet. 1992, 339:393-4. 10.1016\/0140-6736(92)90080-m","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)62083-7","article-title":"Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study","volume":"66","author":"Service FJ","year":"1991","unstructured":"Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991, 66:711-9. 10.1016\/s0025-6196(12)62083-7","journal-title":"Mayo Clin Proc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2022.0707","article-title":"The incidence of insulinoma in Western Sweden between 2002 and 2019","volume":"35","author":"Svensson E","year":"2022","unstructured":"Svensson E, Muth A, Hedenstr\u00f6m P, Ragnarsson O. The incidence of insulinoma in Western Sweden between 2002 and 2019. Ann Gastroenterol. 2022, 35:434-40. 10.20524\/aog.2022.0707","journal-title":"Ann Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000110","article-title":"A systematic review of localization, surgical treatment options, and outcome of insulinoma","volume":"43","author":"Mehrabi A","year":"2014","unstructured":"Mehrabi A, Fischer L, Hafezi M, et al.. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014, 43:675-86. 10.1097\/MPA.0000000000000110","journal-title":"Pancreas"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-013-9262-y","article-title":"Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature","volume":"24","author":"La Rosa S","year":"2013","unstructured":"La Rosa S, Pariani D, Calandra C, Marando A, Sessa F, Cortese F, Capella C. Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature. Endocr Pathol. 2013, 24:213-9. 10.1007\/s12022-013-9262-y","journal-title":"Endocr Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab559","article-title":"Clinical characteristics and incidences of benign and malignant insulinoma using a national inpatient database in Japan","volume":"106","author":"Kurakawa KI","year":"2021","unstructured":"Kurakawa KI, Okada A, Manaka K, et al.. Clinical characteristics and incidences of benign and malignant insulinoma using a national inpatient database in Japan. J Clin Endocrinol Metab. 2021, 106:3477-86. 10.1210\/clinem\/dgab559","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/XCS.0000000000000307","article-title":"Comparison between sporadic and multiple endocrine neoplasia type 1-associated insulinoma","volume":"235","author":"Sada A","year":"2022","unstructured":"Sada A, Habermann EB, Szabo Yamashita T, et al.. Comparison between sporadic and multiple endocrine neoplasia type 1-associated insulinoma. J Am Coll Surg. 2022, 235:756-63. 10.1097\/XCS.0000000000000307","journal-title":"J Am Coll Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200608000-00018","article-title":"Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient","volume":"30","author":"Perren A","year":"2006","unstructured":"Perren A, Wiesli P, Schmid S, et al.. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient. Am J Surg Pathol. 2006, 30:1047-51. 10.1097\/00000478-200608000-00018","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0142","article-title":"Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review","volume":"16","author":"Dworakowska D","year":"2009","unstructured":"Dworakowska D, Grossman AB. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer. 2009, 16:45-58. 10.1677\/ERC-08-0142","journal-title":"Endocr Relat Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3810","article-title":"Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1","volume":"4","author":"Cao Y","year":"2013","unstructured":"Cao Y, Gao Z, Li L, et al.. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat Commun. 2013, 4:2810. 10.1038\/ncomms3810","journal-title":"Nat Commun"},{"key":"ref19","article-title":"Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas","volume":"8","author":"Wang H","year":"2017","unstructured":"Wang H, Bender A, Wang P, et al.. Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas. Nat Commun. 2017, 8:767.","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18839-1","article-title":"Aberrant methylation underlies insulin gene expression in human insulinoma","volume":"11","author":"Karakose E","year":"2020","unstructured":"Karakose E, Wang H, Inabnet W, et al.. Aberrant methylation underlies insulin gene expression in human insulinoma. Nat Commun. 2020, 11:5210. 10.1038\/s41467-020-18839-1","journal-title":"Nat Commun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1901-y","article-title":"Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass","volume":"53","author":"Reubi JC","year":"2010","unstructured":"Reubi JC, Perren A, Rehmann R, et al.. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia. 2010, 53:2641-5. 10.1007\/s00125-010-1901-y","journal-title":"Diabetologia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0321","article-title":"Aggressive versus indolent insulinomas: new clinicopathological insights","volume":"30","author":"Hackeng WM","year":"2023","unstructured":"Hackeng WM, Brosens LA, Dreijerink KM. Aggressive versus indolent insulinomas: new clinicopathological insights. Endocr Relat Cancer. 2023, 30:e220321. 10.1530\/ERC-22-0321","journal-title":"Endocr Relat Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac207","article-title":"Molecular imaging of neuroendocrine neoplasms","volume":"107","author":"Refardt J","year":"2022","unstructured":"Refardt J, Hofland J, Wild D, Christ E. Molecular imaging of neuroendocrine neoplasms. J Clin Endocrinol Metab. 2022, 107:e2662-70. 10.1210\/clinem\/dgac207","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0056","article-title":"Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation","volume":"162","author":"Druce MR","year":"2010","unstructured":"Druce MR, Muthuppalaniappan VM, O'Leary B, et al.. Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. Eur J Endocrinol. 2010, 162:971-8. 10.1530\/EJE-10-0056","journal-title":"Eur J Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0362","article-title":"Interventional vs surgical procedures in localized\/nonmetastatic insulinomas (ablation vs surgery)","volume":"30","author":"Sada A","year":"2023","unstructured":"Sada A, McKenzie TJ, Vella A, Levy MJ, Halfdanarson TR. Interventional vs surgical procedures in localized\/nonmetastatic insulinomas (ablation vs surgery). Endocr Relat Cancer. 2023, 30:e220362. 10.1530\/ERC-22-0362","journal-title":"Endocr Relat Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13528","article-title":"Multidisciplinary management of refractory insulinomas","volume":"88","author":"Brown E","year":"2018","unstructured":"Brown E, Watkin D, Evans J, Yip V, Cuthbertson DJ. Multidisciplinary management of refractory insulinomas. Clin Endocrinol (Oxf). 2018, 88:615-24. 10.1111\/cen.13528","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01901","article-title":"Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies","volume":"152","author":"Vezzosi D","year":"2005","unstructured":"Vezzosi D, Bennet A, Rochaix P, et al.. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol. 2005, 152:757-67. 10.1530\/eje.1.01901","journal-title":"Eur J Endocrinol"},{"key":"ref28","article-title":"Suppression of hypoglycemia by DL-propranolol in malignant insulinoma","volume":"299","author":"Blum I","year":"1978","unstructured":"Blum I, Aderka D, Doron M, Laron Z. Suppression of hypoglycemia by DL-propranolol in malignant insulinoma. N Engl J Med. 1978, 299:487.","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2743","article-title":"Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"23","author":"Brabander T","year":"2017","unstructured":"Brabander T, van der Zwan WA, Teunissen JJ, et al.. Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors. Clin Cancer Res. 2017, 23:4617-24. 10.1158\/1078-0432.CCR-16-2743","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao JC","year":"2011","unstructured":"Yao JC, Shah MH, Ito T, et al.. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011, 364:514-23. 10.1056\/NEJMoa1009290","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MEJ.0b013e3282aa3f70","article-title":"Factitious hypoglycaemia in a nondiabetic patient","volume":"15","author":"Ameh V","year":"2008","unstructured":"Ameh V, Speak N. Factitious hypoglycaemia in a nondiabetic patient. Eur J Emerg Med. 2008, 15:59-60. 10.1097\/MEJ.0b013e3282aa3f70","journal-title":"Eur J Emerg Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068294","article-title":"Factitious hypoglycemia caused by taking a sulfonylurea drug [Article in German]","volume":"112","author":"Siegel EG","year":"1987","unstructured":"Siegel EG, Mayer G, Nauck M, Creutzfeldt W. Factitious hypoglycemia caused by taking a sulfonylurea drug [Article in German]. Dtsch Med Wochenschr. 1987, 112:1575-9. 10.1055\/s-2008-1068294","journal-title":"Dtsch Med Wochenschr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-20216","article-title":"Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia [Article in German]","volume":"127","author":"Meier JJ","year":"2002","unstructured":"Meier JJ, H\u00fccking K, Gr\u00fcneklee D, Schmiegel W, Nauck MA. Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia [Article in German]. Dtsch Med Wochenschr. 2002, 127:375-8. 10.1055\/s-2002-20216","journal-title":"Dtsch Med Wochenschr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0902-0","article-title":"Spontaneous hypoglycemia: diagnostic evaluation and management","volume":"53","author":"Kandaswamy L","year":"2016","unstructured":"Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine. 2016, 53:47-57. 10.1007\/s12020-016-0902-0","journal-title":"Endocrine"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/NHH.0000000000000584","article-title":"Hypoglycemia in diabetes mellitus","volume":"35","author":"Freeland B","year":"2017","unstructured":"Freeland B. Hypoglycemia in diabetes mellitus. Home Healthc Now. 2017, 35:414-9. 10.1097\/NHH.0000000000000584","journal-title":"Home Healthc Now"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.62591","article-title":"Factitious hypoglycemia caused by a unique pattern of drug use: a case report","volume":"16","author":"Akbari M","year":"2018","unstructured":"Akbari M, Soltani A, Reza Mohajeri-Tehrani M, Aghaei Meybodi H, Sadat Mousavi Fakhr I, Mahmoud Sajjadi-Jazi S. Factitious hypoglycemia caused by a unique pattern of drug use: a case report. Int J Endocrinol Metab. 2018, 16:e62591. 10.5812\/ijem.62591","journal-title":"Int J Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.893.150","article-title":"Evaluation of patients admitted with hypoglycaemia to a teaching hospital in Central Anatolia","volume":"76","author":"G\u00fcven M","year":"2000","unstructured":"G\u00fcven M, Bayram F, G\u00fcven K, Kelestimur F. Evaluation of patients admitted with hypoglycaemia to a teaching hospital in Central Anatolia. Postgrad Med J. 2000, 76:150-2. 10.1136\/pmj.76.893.150","journal-title":"Postgrad Med J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-2-252","article-title":"Factitious hypoglycemia due to surreptitious administration of insulin: diagnosis, treatment, and long-term follow-up","volume":"108","author":"Grunberger G","year":"1988","unstructured":"Grunberger G, Weiner JL, Silverman R, Taylor S, Gorden P. Factitious hypoglycemia due to surreptitious administration of insulin: diagnosis, treatment, and long-term follow-up. Ann Intern Med. 1988, 108:252-7. 10.7326\/0003-4819-108-2-252","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427795-three-interesting-cases-of-hypoglycemia-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:35:07Z","timestamp":1767454507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427795-three-interesting-cases-of-hypoglycemia-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.100688","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,3]]}}}